The estimated Net Worth of Kimberly S Taylor is at least $31.8 Milión dollars as of 30 November 2017. Kimberly Taylor owns over 8,125 units of CME Inc stock worth over $26,359,768 and over the last 20 years Kimberly sold CME stock worth over $5,433,978.
Kimberly has made over 47 trades of the CME Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently Kimberly exercised 8,125 units of CME stock worth $681,525 on 30 November 2017.
The largest trade Kimberly's ever made was exercising 13,000 units of CME Inc stock on 15 March 2015 worth over $655,070. On average, Kimberly trades about 1,640 units every 64 days since 2004. As of 30 November 2017 Kimberly still owns at least 120,590 units of CME Inc stock.
You can see the complete history of Kimberly Taylor stock trades at the bottom of the page.
Over the last 21 years, insiders at CME Inc have traded over $264,111,034 worth of CME Inc stock and bought 77,667 units worth $15,169,350 . The most active insiders traders include Terrence A Duffy, Phupinder Gill a Bryan T Durkin. On average, CME Inc executives and independent directors trade stock every 10 days with the average trade being worth of $863,868. The most recent stock trade was executed by Bryan T Durkin on 30 August 2024, trading 7,593 units of CME stock currently worth $1,629,382.
as the world's leading and most diverse derivatives marketplace, cme group (www.cmegroup.com) is where the world comes to manage risk. cme group exchanges offer the widest range of global benchmark products across all major asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate. cme group brings buyers and sellers together through its cme globex® electronic trading platform and its trading facilities in new york and chicago. cme group also operates cme clearing, one of the world’s leading central counterparty clearing provider in the world, which offers clearing and settlement services for exchange-traded contracts, as well as for over-the-counter derivatives transactions through cme clearport®. these products and services ensure that businesses everywhere can substantially mitigate counterparty credit risk in both listed and over-the-counter derivatives markets.
CME Inc executives and other stock owners filed with the SEC include: